Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00663481 · ClinicalTrials.gov registry record · Phase 1
A Clinical Trial of CoFactor Formulations and Leucovorin Administered Intravenously in Healthy, Adult Subjects.
A Phase 1 study of Healthy Adults, sponsored by Mast Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT00663481: Completed Phase 1 study of Healthy Adults, sponsored by Mast Therapeutics.
NCT00663481 is a Phase 1 study of Healthy Adults that has completed, run by Mast Therapeutics. The registered enrollment target is 15 participants, below the 86-participant average among 33 other Healthy Adults trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00663481, a Phase 1 study of Healthy Adults, has completed, sponsored by Mast Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the safety and tolerability of CoFactor in healthy subjects.
Conditions Studied
Interventions
- DRUG Leucovorin
- DRUG CoFactor
Study Locations (1)
Maryland
- Parexel International - Baltimore CPRU - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2008-04 |
| Est. Completion | 2008-05 |
| Phase | Phase 1 |
What the finished NCT00663481 record still lists
NCT00663481 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 86-participant average among 33 other Healthy Adults trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Healthy Adults appearing as the primary indexed condition, and to 2 interventions - of which Leucovorin is the first listed.
NCT00663481 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00663481 about?
NCT00663481 is a clinical study titled "A Clinical Trial of CoFactor Formulations and Leucovorin Administered Intravenously in Healthy, Adult Subjects.". The purpose of this study is to determine the safety and tolerability of CoFactor in healthy subjects.
What is the current status of trial NCT00663481?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2008-04. Estimated completion is 2008-05.
What conditions does trial NCT00663481 study?
This clinical trial studies the following conditions: Healthy Adults.
What interventions are being tested in trial NCT00663481?
The interventions under investigation include: Leucovorin (DRUG), CoFactor (DRUG).
Who is sponsoring clinical trial NCT00663481?
This trial is sponsored by Mast Therapeutics, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00663481 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Adults
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00663481's enrollment target sits among peer trials
15 32nd of 33 higher than 2 of 33 other Healthy Adults trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Adults trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of EDG-15400 in Healthy Adults
RECRUITING · Phase 1
-
A Study to Learn About How the Study Medicines Called Itraconazole and Probenecid Change How the Body Processes PF-07220060
RECRUITING · Phase 1
-
Phase 1a Single Ascending Dose Study of MIB-725 in Healthy Adults
RECRUITING · Phase 1
-
Safety and Efficacy of Injectable Klotho Plasmid Gene Therapy in Humans
RECRUITING · Phase 1
-
Tracing the Metabolic Flux of Orally Administered NAD+ Precursors
RECRUITING · Phase 1
-
The Dose Response of Prednisone on Biochemical and Clinical Makers in Adult Healthy Volunteers
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia